-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PHI-101 in Refractory Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PHI-101 in Refractory Acute Myeloid Leukemia Drug Details:PHI-101 is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BNT-142 in Metastatic Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BNT-142 in Metastatic Ovarian Cancer Drug Details: BNT-142 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ravulizumab LA in Lupus Nephritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ravulizumab LA in Lupus Nephritis Drug Details: Ravulizumab (Ultomiris) is a humanized monoclonal antibody. It...
-
Product Insights
![]()
El-Fayum Development Lease Field, Egypt
El-Fayum Development Lease upstream field is located in Faiyum Governorate, Egypt. The upstream field is owned by IPR Lake Qarun Petroleum Co (55%); Pharos El Fayum Co (45%). It is operated by IPR Lake Qarun Petroleum Co. The project started its operations in 2009. El-Fayum Development Lease Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production,...
-
Sector Analysis
New![]()
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Company Profile
![]()
Ra Medical Systems Inc – Company Profile
Ra Medical Systems Inc (Ra Medical Systems) is a medical device company. It develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its products portfolio include dabra system a versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. It also provides pharos a monochromatic, xenon-chlorine, and 308-nm UVB excimer laser for the treatment of chronic...
Add to Basket -
Product Insights
![]()
Ra Medical Systems Inc Pipeline Insight and Competitive Landscape, 2023
Ra Medical Systems Inc (Ra Medical Systems) is a medical device company. It develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its products portfolio include dabra system a versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. It also provides pharos a monochromatic, xenon-chlorine, and 308-nm UVB excimer laser for the treatment of chronic...
-
Product Insights
![]()
Acute Myelocytic Leukemia (AML) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
AML Pipeline Products Market Report Overview Acute myelocytic leukemia (AML), also known as acute myelogenous leukemia is a type of cancer that affects the blood and the bone marrow. Immature white blood cells accumulate in the bone marrow thus blocking the production of normal blood cells. These cells further enter the bloodstream and spread to the other parts of the body. Symptoms of AML include fatigue, fever, bleeding, breathing problems, and weight loss. The predisposing factors involved are exposed to...
-
Product Insights
![]()
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ovarian Cancer Pipeline Products Market Report Overview Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, and changes in bowel habits, such as constipation, loss of appetite, and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy, and radiation...
-
Product Insights
![]()
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Drugs Market Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment includes...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – PHI-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PHI-101 Drug Details PHI-101 is under development for the treatment of relapsed and refractory...
-
Product Insights
![]()
Leishmaniasis (Kala-Azar) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leishmaniasis (Kala-Azar) is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms of Kala-Azar include weight loss, low blood counts, enlargement of the liver and spleen, and fever. Treatment includes anti-parasitic drugs. The Leishmaniasis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Leishmaniasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
![]()
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fallopian Tube Cancer symptoms may include abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish and a pelvic mass at the time of diagnosis. The Fallopian Tube Cancer pipeline drugs market research report provides an analysis of the Fallopian Tube Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the...
-
Product Insights
![]()
Peritoneal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Peritoneal cancer develops in the peritoneum, a thin, delicate sheet that lines the inside wall of the abdomen and covers the uterus, and extends over the bladder and rectum. Peritoneal cancer usually manifests with abdominal distention and diffuse nonspecific abdominal pain secondary to ascites. Peritoneal cancer symptoms may include shortness of breath, rectal bleeding, loss of appetite, frequent urination, constipation, nausea or diarrhea, and feeling of fullness, even after a light meal. Treatment includes options such as chemotherapy, surgery, biological...
-
Product Insights
![]()
Zika Virus Infections Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Zika Virus Infections Global Clinical Trials Review, H2, 2016" provides an overview of Zika Virus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Zika Virus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
![]()
China Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices.
“What is covered in the report about the “China Anesthesia and Respiratory Devices Market”? GlobalData’s “China Anesthesia and Respiratory Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the China Anesthesia and Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Airway Management, Anesthesia Devices, Diagnostic and Measurement Devices and Respiratory Devices. The China Anesthesia and Respiratory Devices Market report provides key information...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.